Two Sigma Securities’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,800
Closed -$1.35M 2855
2024
Q3
$1.35M Buy
5,800
+1,500
+35% +$308K 0.02% 732
2024
Q2
$868K Sell
4,300
-9,400
-69% -$1.69M 0.01% 1163
2024
Q1
$2.35M Sell
13,700
-2,600
-16% -$485K 0.02% 684
2023
Q4
$3.54M Buy
16,300
+8,500
+109% +$1.46M 0.03% 475
2023
Q3
$1.24M Buy
7,800
+5,600
+255% +$1.25M 0.01% 908
2023
Q2
$634K Buy
+2,200
New +$668K 0.01% 1269
2022
Q2
Sell
-800
Closed -$213K 2724
2022
Q1
$213K Buy
+800
New +$196K 0.01% 1707

Other funds holding PODD

Two Sigma Securities's PODD Position: Q2 2026 in Review

Two Sigma Securities sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,023 shares — an estimated $215K sold.

Two Sigma Securities first reported a position in PODD in Q2 2021 and held it in 8 quarters. The position peaked at $959K in Q3 2023. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Two Sigma Securities reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,023 Insulet shares in Q2 2026, an estimated $215K.
  • Two Sigma Securities first reported a position in Insulet in Q2 2021 and held it in 8 quarters.
  • Two Sigma Securities's Insulet position peaked at $959K in Q3 2023.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.